| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |